View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Encorafenib 300 / Binimetinib 45 / Cetuximab 250, Colorectal Carcinoma, Cycle 2+
Protocol-ID: 1407 V1.2 (Mini), ENCO300/BINI45/CETU250, colorect. Ca, C2+Indication(s)
- Colon Cancer; ICD-10 C18.0, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C19
Links
- Encorafenib (braftovi) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 07.11.2021